Serologic markers of hepatitis - B infection in bronchial asthma

Raghunanthan, T and Deepak, Arjundas and Sivakumar, M R and Nalini, Krishnan and Basheer, Ahmed and Thiruvengadam, K V and Kumaraswami, V and Suniti, Solomon and Thiyagarajan, S P (1984) Serologic markers of hepatitis - B infection in bronchial asthma. Lung India, 2 (2). pp. 192-194. ISSN Print: 0970-2113; Online: 0974-598X

[thumbnail of 198410.pdf]
198410.pdf - Published Version

Download (252kB)


Subjected to frequent parenteral drug and allergen administration, patients with bronchial asthma are likely to be at risk of contracting hepatitis B infection. In addition, those receiving immunotherapy are subjected to more frequent parenteral medication and hence are at a greater risk than those on only pharmacologic therapy. This problem was studied among 60 patients with bronchial asthma – 30 on immunotherapy and 30 on pharmacotherapy. A higher prevalence of Hepatitis B surface antigen (HBs Ag) among patients with bronchial asthma than in the general population was detected but no difference was found between the two groups.

Item Type: Article
Subjects: Tuberculosis > Clinical Research
Divisions: Clinical Research
Depositing User: Dr. Rathinasabapati R
Date Deposited: 07 Aug 2013 09:26
Last Modified: 17 Mar 2016 09:06

Actions (login required)

View Item View Item